NovaBay Pharmaceuticals, Inc. Quarterly Other Assets, Current in USD from Q2 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
NovaBay Pharmaceuticals, Inc. quarterly Other Assets, Current history and growth rate from Q2 2012 to Q3 2024.
  • NovaBay Pharmaceuticals, Inc. Other Assets, Current for the quarter ending September 30, 2024 was $116K, a 61.1% increase year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $116K +$44K +61.1% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $94K -$103K -52.3% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $96K -$36K -27.3% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $81K -$78K -49.1% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $72K -$37K -33.9% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $197K +$46K +30.5% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $132K -$96K -42.1% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $159K +$30K +23.3% Dec 31, 2022 10-K 2024-03-26
Q3 2022 $109K -$8K -6.84% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $151K +$54K +55.7% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $228K +$97K +74% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $129K +$27K +26.5% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $117K +$40K +51.9% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $97K -$17K -14.9% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $131K +$37K +39.4% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $102K -$57K -35.8% Dec 31, 2020 10-K 2022-03-29
Q3 2020 $77K -$202K -72.4% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $114K -$138K -54.8% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $94K -$254K -73% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $159K -$59K -27.1% Dec 31, 2019 10-K 2021-03-25
Q3 2019 $279K +$45K +19.2% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $252K +$37K +17.2% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $348K +$111K +46.8% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $218K -$136K -38.4% Dec 31, 2018 10-K 2020-03-26
Q3 2018 $234K +$46K +24.5% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $215K -$59K -21.5% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $237K -$218K -47.9% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $354K +$60K +20.4% Dec 31, 2017 10-K 2019-03-29
Q3 2017 $188K -$98K -34.3% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 $274K +$271K +9033% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 $455K Mar 31, 2017 10-Q 2017-05-11
Q4 2016 $294K +$33K +12.6% Dec 31, 2016 10-K 2018-03-21
Q3 2016 $286K -$3.1M -91.5% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 $3K -$7.21M -100% Jun 30, 2016 10-Q 2016-08-11
Q4 2015 $261K -$5.17M -95.2% Dec 31, 2015 10-K 2017-03-23
Q3 2015 $3.38M +$2.13M +170% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 $7.21M +$3.4M +89.3% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 $5.6M +$740K +15.2% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 $5.43M -$7.62M -58.4% Dec 31, 2014 10-K 2015-03-26
Q3 2014 $1.25M -$2.63M -67.8% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 $3.81M -$7.6M -66.6% Jun 30, 2014 10-Q 2014-07-31
Q1 2014 $4.86M -$8.33M -63.2% Mar 31, 2014 10-Q 2014-05-01
Q4 2013 $13.1M -$3.82M -22.6% Dec 31, 2013 10-K 2014-03-06
Q3 2013 $3.89M -$8M -67.3% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 $11.4M +$1.03M +9.95% Jun 30, 2013 10-Q 2013-08-01
Q1 2013 $13.2M Mar 31, 2013 10-Q 2013-05-02
Q4 2012 $16.9M Dec 31, 2012 10-K 2013-03-14
Q3 2012 $11.9M Sep 30, 2012 10-Q 2012-11-01
Q2 2012 $10.4M Jun 30, 2012 10-Q 2012-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.